<?xml version="1.0" encoding="UTF-8"?>
<ref id="ajh25238-bib-0038">
 <label>38</label>
 <mixed-citation publication-type="journal" id="ajh25238-cit-0038">
  <string-name>
   <surname>Kantarjian</surname>
   <given-names>HM</given-names>
  </string-name>, 
  <string-name>
   <surname>O'Brien</surname>
   <given-names>S</given-names>
  </string-name>, 
  <string-name>
   <surname>Huang</surname>
   <given-names>X</given-names>
  </string-name>, et al. 
  <article-title>Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: comparison with historical experience</article-title>. 
  <source xml:lang="en">Cancer.</source>
  <year>2007</year>;
  <volume>109</volume>:
  <fpage>1133</fpage>‚Äê
  <lpage>1137</lpage>.
  <pub-id pub-id-type="pmid">17315156</pub-id>
 </mixed-citation>
</ref>
